Overview

Application of a TBE-Vaccine in Obese Persons

Status:
Unknown status
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
Obese people have an altered immune responsiveness. The present study investigates whether this influences immune responses to booster vaccinations (i. e. booster vaccination with TBE vaccine "FSME Immun") and if a modification of vaccination schedules is needed. Obese adults (BMI >30) >18 - 60 years are compared with adults with normal weight (BMI <25) concerning TBE-NT- antibody titers, TBE- NT antibody titer course and cellular immunity. Metabolic parameters and sexual hormones will be tested and compared as well.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Vaccines